Unbound MEDLINE

Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors. Bioorganic & medicinal chemistry [Bioorg Med Chem] Journal article

 
TitleSynthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
Author(s)Zhan P, Liu X, Zhu J, Fang Z, Li Z, Pannecouque C, Clercq ED 
InstitutionInstitute of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, No. 44 Wenhuaxi Road, Jinan 250012, PR China.
SourceBioorg Med Chem 2009 Jul 18.
AbstractA series of 2-(1-aryl-1H-imidazol-2-ylthio)acetamide [imidazole thioacetanilide (ITA)] derivatives were synthesized and evaluated as potent inhibitors of human immunodeficiency virus type-1 (HIV-1). Among them, the most potent HIV-1 inhibitors were 4a5 (EC(50)=0.18muM), and 4a2 (EC(50)=0.20muM), which were more effective than the lead compound L1 (EC(50)=2.053muM) and the reference drugs nevirapine and delavirdine. The preliminary structure-activity relationship (SAR) of the newly synthesized congeners is discussed.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19643613
  
Advertise on this site.